Johnson & Johnson Wins FDA Approval for Ottava Robotic Surgery System, Challenging Market Leader Intuitive Surgical
Johnson & Johnson has secured FDA approval for its Ottava robotic surgical system, enabling the healthcare giant to compete in the soft-tissue robotic surgery market currently dominated by Intuitive Surgical. The system is cleared for multiple general surgery procedures.